Medical specialists from United Kingdom tagged as investigators in clinical trials studying Small Cell Lung Carcinoma
Total 26 results
-
Adam Hassani, MDSeen in:
- South Shields, South Tyneside
- Sunderland, Sunderland Royal Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Alison Brewster, MDSeen in:
- Haverfordwest, Withybush Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Andreas Polychronis, MDSeen in:
- Northwood, Mount Vernon Cancer Centre
- Stevenage, Lister Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Andrew Conn, MDSeen in:
- Bradford, Bradford Teaching Hospitals
Trials:- NCT04056247 (Principal Investigator)
-
Anirban Chatterjee, MDSeen in:
- Shrewsbury, The Shrewsbury and Telford Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Corinne Faivre-Finn, MDSeen in:
- Manchester, The Christie NHS Foundation Trust
Trials:- NCT04790253 (Principal Investigator)
-
David Farrugia, MDSeen in:
- Cheltenham, Cheltenham General Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Fiona McDonald, MDSeen in:
- Sutton, Royal Marsden Hospital - Sutton
Trials:- NCT04790253 (Principal Investigator)
-
Gareth Ayre, MDSeen in:
- Bristol, University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre
Trials:- NCT04790253 (Principal Investigator)
-
Gillian Price, MDSeen in:
- Aberdeen, Aberdeen Royal Infirmary
Trials:- NCT04056247 (Principal Investigator)
-
Helen CheleySeen in:
- Swansea, Swansea Bay UHB Singleton Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Hendrik-Tobias ArkenauSeen in:
- London, Sarah Cannon Research Institute UK
Trials:- NCT04032704 (Principal Investigator)
- NCT04691804 (Principal Investigator)
Conditions:- Melanoma;
- Small Cell Lung Cancer;
- Prostate Cancer;
- Gastric Adenocarcinoma;
- Head and Neck Squamous Cell Carcinoma;
- Esophageal Squamous Cell Carcinoma;
- Gastroesophageal Junction Adenocarcinoma;
- Non-small Cell Lung Cancer, Squamous;
- Non-small Cell Lung Cancer, Non-squamous;
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Ian ChauSeen in:
- London, The Royal Marsden Hospital
- Other, London, The Royal Marsden Hospital
- Other, Sutton, The Royal Marsden Hospital (Surrey)
- Surrey, Sutton, Royal Marsden Hospital
- Sutton, The Royal Marsden Hospital (Surrey)
Trials:- NCT04662255 (Principal Investigator)
- NCT04032704 (Principal Investigator)
- NCT04569032 (Principal Investigator)
Conditions:- Lymphoma, Mantle-Cell;
- Melanoma;
- Small Cell Lung Cancer;
- Prostate Cancer;
- Gastric Adenocarcinoma;
- Head and Neck Squamous Cell Carcinoma;
- Esophageal Squamous Cell Carcinoma;
- Gastroesophageal Junction Adenocarcinoma;
- Non-small Cell Lung Cancer, Squamous;
- Non-small Cell Lung Cancer, Non-squamous;
- Peripheral T-cell Lymphoma
-
Jeff EvansSeen in:
- Glasgow, Cancer Research UK Clinical trials; Unit Partner in CaCTUS- Cancer clinical trials Unit Scotland; Beatson West of Scotland Cancer Centre
- Glasgow, The Beatson West of Scotland Cancer Centre
- Other, Glasgow, NHS Greater Glasgow and Clyde (NHSGGC) - The Beatson West of Scotland Cancer Centre
Trials:- NCT05571839 (Principal Investigator)
- NCT04032704 (Principal Investigator)
- NCT05120596 (Principal Investigator)
- NCT05985655 (Principal Investigator)
Conditions:- Colorectal Neoplasms;
- Pancreatic Neoplasms;
- Mesothelioma;
- Non-small Cell Lung Cancer;
- Cutaneous Melanoma;
- Melanoma;
- Small Cell Lung Cancer;
- Prostate Cancer;
- Gastric Adenocarcinoma;
- Head and Neck Squamous Cell Carcinoma;
- Esophageal Squamous Cell Carcinoma;
- Gastroesophageal Junction Adenocarcinoma;
- Non-small Cell Lung Cancer, Squamous;
- Non-small Cell Lung Cancer, Non-squamous;
- Advanced Solid Tumor
-
Johann De Bono, MDSeen in:
- Surrey, Sutton, The Royal Marsden NHS Trust
Trials:- NCT05551117 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm
-
Kerstie Johnson, MDSeen in:
- Nottingham, Nottingham University Hospitals NHS Trust - City Hospital
Trials:- NCT04790253 (Principal Investigator)
-
Khurum KhanSeen in:
- London, UCL Cancer Institute
Trials:- NCT04032704 (Principal Investigator)
-
Kirsty MacLennan, MDSeen in:
- Edinburgh, NHS Lothian - Western General Hospital
Trials:- NCT04790253 (Principal Investigator)
-
Louise Medley, MDSeen in:
- Torquay, Torbay Hospital
Trials:- NCT04056247 (Principal Investigator)
-
Mark Tuthill, MDSeen in:
- Oxford, Oxford University Hospitals NHS- Churchill Hospital
Trials:- NCT05551117 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm
-
Matthew Hatton, MDSeen in:
- Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital
Trials:- NCT04790253 (Principal Investigator)
-
Matthew KrebsSeen in:
- Manchester, The Christie Hospital
- Manchester, The Christie NHS Foundation Trust
Trials:- NCT04032704 (Principal Investigator)
- NCT05722886 (Principal Investigator)
Conditions:- Melanoma;
- Small Cell Lung Cancer;
- Prostate Cancer;
- Gastric Adenocarcinoma;
- Head and Neck Squamous Cell Carcinoma;
- Esophageal Squamous Cell Carcinoma;
- Gastroesophageal Junction Adenocarcinoma;
- Non-small Cell Lung Cancer, Squamous;
- Non-small Cell Lung Cancer, Non-squamous;
- Solid Tumor;
- Haematological Malignancy
-
Nadia YousafSeen in:
- London, Royal Marsden NHS Foundation Trust - London and Surrey
Trials:- NCT04440800 (Principal Investigator)
-
Olivia CurtisSeen in:
- London, Royal Marsden NHS Foundation Trust - London and Surrey
Trials:- NCT04440800 (Sub-Investigator)
-
Timothy Sevitt, MDSeen in:
- Maidstone, Maidstone & Tunbridge Wells NHS Trust - Maidstone Hospital
Trials:- NCT04790253 (Principal Investigator)
-
Tom Geldart, MDSeen in:
- Bournemouth, Royal Bournemouth General Hospital
Trials:- NCT04056247 (Principal Investigator)
Clinical Trials on Small Cell Lung Carcinoma
-
National Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Bladder Small Cell Neuroendocrine Carcinoma | Extrapulmonary Small Cell Neuroendocrine Carcinoma | Recurrent Lung... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedExtensive Stage Lung Small Cell CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Institute on Aging (NIA)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Extensive Stage Lung Small Cell Carcinoma | Unresectable Lung Non-Small Cell Carcinoma | Advanced Lung Non-Small Cell Carcinoma | Advanced... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedCarcinoma, Non-Small Cell Lung | Carcinoma, Small-Cell LungUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlatinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Extensive Stage Lung Small Cell Carcinoma | Refractory Extensive Stage Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States